openPR Logo
Press release

Boster Bio Launches Free Antibody Validation Service to Transform Research Reproducibility

06-26-2025 06:04 PM CET | Fashion, Lifestyle, Trends

Press release from: Getnews

/ PR Agency: Spine PR
Boster Bio Launches Free Antibody Validation Service

Image: https://www.globalnewslines.com/uploads/2025/06/1750910150.jpg

In a bold move that could reshape the future of biomedical research, Boster Bio is launching a Free Antibody Validation Program [https://www.bosterbio.com/promotions/free-validation-for-picoband-antibodies]-giving scientists the power to test antibodies under their exact experimental conditions before purchase. It's a first-of-its-kind, no-cost service that tackles one of science's most frustrating pain points: unreliable antibodies.

"For too long, researchers have had to gamble on antibodies that may or may not work," said CJ Xia, Founder and VP of Boster Bio. "We believe that's unacceptable. Our free validation service gives you proof before you pay-so your research runs smoother, faster, and with far fewer surprises."

Why It Matters

Antibodies are the backbone of modern life sciences. Yet according to studies, over 50% of research antibodies are poorly validated, leading to inconsistent results, failed experiments, and wasted budgets.

Boster Bio's solution? A fast, AI-assisted validation pipeline that tests antibodies for specificity and performance using over 500 in-house tissue and lysate types across applications like Western blot (WB), IHC, IF, ELISA, FC, and IP-all tailored to the researcher's exact assay needs.

How It Works:

*
Submit in 2 Minutes: Fill out a quick online form or reply by email with your biomarker list, sample types, and applications.

*
We Test for You: Our team validates your requested antibodies in-house-no samples or reagents needed from your lab.

*
Fast Turnaround: You'll receive a full validation report, including protocols and results, in 4-10 days.

Built for Today's Research Environment

With time and funding tighter than ever, researchers deserve tools that help them focus on publishing, not troubleshooting. Boster Bio's Free Validation Service eliminates trial-and-error by front-loading the proof. Labs can even submit up to 100 biomarkers at once, making it ideal for screening large panels.

"We're not just providing reagents," Xia adds. "We're changing expectations. In five years, people will look back and wonder how they ever ordered antibodies without seeing validation data first. This is the new normal."

Try It Now

Interested researchers can submit their validation requests visit: https://www.bosterbio.com/promotions/free-validation-for-picoband-antibodies

Precision, On Demand: Custom Monoclonal Antibodies Designed for Your Research

In addition to its free validation service, Boster Bio offers custom monoclonal antibody production [https://www.bosterbio.com/services/custom-monoclonal-antibody-development-service]-a fast, tailored solution for researchers who need highly specific, high-affinity antibodies built from the ground up.

Leveraging decades of expertise in immunogen design and hybridoma technology, Boster Bio guides researchers through every step: from antigen design and immunization to hybridoma screening and large-scale production.

"We design each antigen strategically-accounting for homology, post-translational modifications, epitope localization, and protein structure-so you get antibodies that hit exactly where you need them," said CJ Xia.

With turnaround times as short as eight weeks, the process balances speed with scientific rigor. Each batch undergoes strict quality controls, including titer testing and cross-reactivity screening, ensuring performance you can trust in assays like WB, IHC, IF, ICC, ELISA, and Flow Cytometry.

Researchers can choose from a growing inventory of over 8,000 antibodies and 500 sample types (including human, mouse, rat, monkey, and zebrafish), or start completely from scratch.

By combining free validation with custom development, Boster Bio now delivers a true end-to-end antibody solution-positioning itself as a single, reliable partner for labs aiming to publish faster, waste less, and innovate more.

About the Company:

Boster Bio is a leading manufacturer of antibodies and ELISA kits critical to advancing life science research. Specializing in custom monoclonal antibody production services and offering free antibody validation, the company supports researchers with high-quality reagents and exceptional service. Based in Pleasanton, CA, Boster Bio continues to innovate in antibody development and immunoassay solutions.
Media Contact
Company Name: Boster Biological Technology
Contact Person: CJ Xia
Email: Send Email [http://www.universalpressrelease.com/?pr=boster-bio-launches-free-antibody-validation-service-to-transform-research-reproducibility]
Phone: (888) 466-3604
Address:3942 Valley Ave
City: Pleasanton
State: CA 94566
Country: United States
Website: https://www.bosterbio.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Boster Bio Launches Free Antibody Validation Service to Transform Research Reproducibility here

News-ID: 4083926 • Views:

More Releases from Getnews

LiTime Unveils World's First Smart
LiTime Unveils World's First Smart "Talking LiFePO4 Battery" T5.0 for RV and Mar …
The first smart lithium battery system in the RV and marine industries to feature an open, protocol-compatible communication ecosystem. LiTime [https://bit.ly/3G3APL8], a global pioneer in energy innovation, has launched its fifth-generation T5.0 technology platform alongside compatible products. The breakthrough solution supports both CAN and RS485 communication protocols, enables OTA updates, and delivers native integration with leading RV and marine energy systems. By dismantling traditional battery data silos, T5.0 establishes intelligent
$69 Million in Recent Contract Awards for Innovative, Disruptive Cybersecurity Leader: Cycurion, Inc. (Nasdaq: CYCU)
$69 Million in Recent Contract Awards for Innovative, Disruptive Cybersecurity L …
Image: https://www.globalnewslines.com/uploads/2025/06/1750910563.jpg $CYCU Reports New 8 Million in Contracts; 2025 Q1 Gross Profit of $677,673, Up 95.4% Year-Over-Year, with 17.5% Gross Margin Increase * Cybersecurity Leader Addressing the Growing Threat of Cyber Attacks and Data Breaches with a Multi-layered SaaS Solution. * Serving Some of the Most Complex Government Agencies and Corporations in the World Including Fortune 100 and 500 Companies. * Clients and Partners Include: US Dept. of
From Floppy Ears to Heroic Cheers: The Heartwarming Rise of Sky the Cockapoo
From Floppy Ears to Heroic Cheers: The Heartwarming Rise of Sky the Cockapoo
Image: https://www.globalnewslines.com/uploads/2025/06/1750940879.jpg In a world hungry for stories that comfort, uplift, and inspire young hearts, author Amir R. Gill introduces not just one, but two enchanting tales centered around a charming Cockapoo named Sky. Through vivid storytelling and heartfelt themes, Enchanting Tales of Sky the Cockapoo and its companion volume Sky Lord Junior - Enchanting Tales of Sky the Cockapoo offer readers an unforgettable journey from puppyhood to purposeful leadership. The first
Awatif Shines Yet Again with '2025 Law Firm of the Year' Award
Awatif Shines Yet Again with '2025 Law Firm of the Year' Award
Awatif Mohammad Shoqi Advocates and Legal Consultancy has once again been recognized as the Full-Service Law Firm [https://www.alrowaad.ae/] of the year in the United Arab Emirates, for the year 2025. The award was bestowed by Global Law Experts [https://globallawexperts.com/award/global-law-experts-global-advisory-experts-awards-2025/#flipbook-global-law-experts-global-advisory-experts-awards-2025/99/]. Image: https://www.globalnewslines.com/uploads/2025/06/dee4da72242e1ccf1f58c4998b5498d2.jpg Commenting on the win, Mrs. Awatif Al Khoury said, "We are truly honored by this recognition. Each achievement of the firm is a testament of the dedication of our team in

All 5 Releases


More Releases for Boster

Global Hyaluronan(Protein) Market Share and Growth2022|Abbexa Ltd(UK), RayBiotec …
QY Research has recently published a new report, titled Global Hyaluronan(Protein) Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hyaluronan(Protein) market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the
Global Carcinoembryonic Antigen Market 2020 Business Strategies – Boster Biolo …
The research report titled “Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025” and published by “Zion Market Research” is an in-depth and dedicated scrutiny of the existing stats of the global Carcinoembryonic Antigen market
Carcinoembryonic Antigen Market Top Key Players- Boster Biological Technology, R …
Zion Market Research published a new 110+ pages industry research “Global Carcinoembryonic Antigen Market Is Set For Moderate Growth, To Reach Around USD 3.23 Billion by 2025” is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data on the
CD163 Market 2019 | World Market Analysis 2025 | Market Leaders – Abbexa Ltd, …
CD163 Marketresearch report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/105774 UpMarketResearch offers a latest published report on “Global CD163 Market Analysis and Forecast 2019 - 2025” delivering key insights and providing a competitive advantage to clients through a
Global Hyaluronan(Protein) Market 2018 - Genetex, Abbexa Ltd, RayBiotech, Boster …
The new market research study on Global Hyaluronan(Protein) Market in-depth market analysis with specific segments such as application, regional markets, end-users, policy analysis, value chain structure, and emerging trends. The Hyaluronan(Protein) market report makes a case for investments in particular regions based on a realistic view of their regulatory environment, manufacturing dynamics and availability of skills and resources.The report’s analysis is based on technical data and industry figures
Global Vero Cell Media Market 2017 - Lonza, Boster Bio, Serana Bio, ATCC
The statistical surveying information incorporated into the Vero Cell Media report is the aftereffect of significant essential and optional research exercises. The report fragments the global market for Vero Cell Media based on makers, item compose, applications, and districts. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the global Vero Cell Media advertise covering key factors, for